Keeping Current

Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC). Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu